{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:15:20Z","timestamp":1787588120979,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.humpath.2022.03.001","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T03:07:40Z","timestamp":1647486460000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Myeloid sarcoma and extramedullary hematopoiesis expand the spectrum of ERG-positive proliferations: an ancillary tool in the diagnosis"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3798-5088","authenticated-orcid":false,"given":"A. Cristina","family":"Vargas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5550-3375","authenticated-orcid":false,"given":"Jennifer","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Burchett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lye Lin","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalba","family":"Zumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9447-1967","authenticated-orcid":false,"given":"Anthony J.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona M.","family":"Maclean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2022.03.001_bib1","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1182\/blood-2010-11-320515","article-title":"Promotion and maintenance of leukemia by ERG","volume":"117","author":"Tsuzuki","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2022.03.001_bib2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/med.21575","article-title":"ETS transcription factors as emerging drug targets in cancer","volume":"40","author":"Hsing","year":"2020","journal-title":"Med Res Rev"},{"key":"10.1016\/j.humpath.2022.03.001_bib3","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.biocel.2011.05.014","article-title":"Acute myeloid leukemia: a central role for the ETS factor ERG","volume":"43","author":"Martens","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.humpath.2022.03.001_bib4","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/PAS.0b013e318206b67b","article-title":"ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma","volume":"35","author":"Miettinen","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.03.001_bib5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/jclinpath-2014-202601","article-title":"ERG expression in chondrogenic bone and soft tissue tumours","volume":"68","author":"Shon","year":"2015","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2022.03.001_bib6","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/modpathol.2013.161","article-title":"ERG and FLI1 protein expression in epithelioid sarcoma","volume":"27","author":"Stockman","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.03.001_bib7","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/ng.3691","article-title":"Deregulation of DUX4 and ERG in acute lymphoblastic leukemia","volume":"48","author":"Zhang","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2022.03.001_bib8","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3324\/haematol.2018.204487","article-title":"ERG deletions in childhood acute lymphoblastic leukemia with DUX4 rearrangements are mostly polyclonal, prognostically relevant and their detection rate strongly depends on screening method sensitivity","volume":"104","author":"Zaliova","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2022.03.001_bib9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ebiom.2016.04.038","article-title":"Genomic profiling of adult and pediatric B-cell acute lymphoblastic leukemia","volume":"8","author":"Liu","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.humpath.2022.03.001_bib10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.anndiagpath.2014.06.001","article-title":"A practical approach to diagnose soft tissue myeloid sarcoma preceding or coinciding with acute myeloid leukemia","volume":"18","author":"Seifert","year":"2014","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2022.03.001_bib11","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2017"},{"key":"10.1016\/j.humpath.2022.03.001_bib12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1751-553X.2011.01361.x","article-title":"State of the art in myeloid sarcoma","volume":"33","author":"Klco","year":"2011","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.humpath.2022.03.001_bib13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.clml.2017.02.027","article-title":"Myeloid sarcoma: presentation, diagnosis, and treatment","volume":"17","author":"Almond","year":"2017","journal-title":"Clin Lymphoma, Myeloma & Leukemia"},{"key":"10.1016\/j.humpath.2022.03.001_bib14","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/ejh.13056","article-title":"Clinicopathological characteristics of de novo and secondary myeloid sarcoma: a monocentric retrospective study","volume":"100","author":"Claerhout","year":"2018","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.humpath.2022.03.001_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/his.13864","article-title":"Clinicopathological and molecular characteristics of extramedullary acute myeloid leukaemia","volume":"75","author":"Ullman","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2022.03.001_bib16","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000253592","article-title":"Prognostic factors of treatment outcomes in patients with granulocytic sarcoma","volume":"122","author":"Lan","year":"2009","journal-title":"Acta Haematol"},{"key":"10.1016\/j.humpath.2022.03.001_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/10245332.2017.1333275","article-title":"Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years","volume":"23","author":"Kaur","year":"2018","journal-title":"Hematology"},{"key":"10.1016\/j.humpath.2022.03.001_bib18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/omcr\/omv070","article-title":"FUS-ERG gene fusion in isolated myeloid sarcoma showing uncommon clinical features","volume":"2016","author":"Ueda","year":"2016","journal-title":"Oxf Med Case Reports"},{"key":"10.1016\/j.humpath.2022.03.001_bib19","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/DAD.0000000000000491","article-title":"ERG is a useful immunohistochemical marker to distinguish leukemia cutis from nonneoplastic leukocytic infiltrates in the skin","volume":"38","author":"Xu","year":"2016","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.humpath.2022.03.001_bib20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/PAI.0000000000000958","article-title":"ERG immunoreactivity in blastic hematolymphoid neoplasms: diagnostic pitfall in the workup of undifferentiated malignant neoplasms","volume":"30","author":"Koo","year":"2022","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2022.03.001_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12308-019-00378-4","article-title":"Survey of ERG expression in normal bone marrow and myeloid neoplasms","volume":"13","author":"Olson","year":"2020","journal-title":"Journal of Hematopathology"},{"key":"10.1016\/j.humpath.2022.03.001_bib22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/modpathol.2015.145","article-title":"Neoplasms derived from plasmacytoid dendritic cells","volume":"29","author":"Facchetti","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.03.001_bib23","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/modpathol.2013.238","article-title":"Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasm","volume":"27","author":"Sangle","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.03.001_bib24","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S2213-8587(21)00178-9","article-title":"Adrenal myelolipomas","volume":"9","author":"Calissendorff","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.humpath.2022.03.001_bib25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.prp.2016.10.014","article-title":"ERG expression in multiple myeloma-A potential diagnostic pitfall","volume":"213","author":"Knief","year":"2017","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.humpath.2022.03.001_bib26","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/PAS.0000000000000727","article-title":"Clinicopathological, cytogenetic, and prognostic analysis of 131 myeloid sarcoma patients","volume":"40","author":"Kawamoto","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.03.001_bib27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1746-1596-2-42","article-title":"Myeloid sarcomas: a histologic, immunohistochemical, and cytogenetic study","volume":"2","author":"Alexiev","year":"2007","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.humpath.2022.03.001_bib28","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.prp.2016.06.014","article-title":"Clinicopathological features of myeloid sarcoma: report of 39 cases and literature review","volume":"212","author":"Wang","year":"2016","journal-title":"Pathol Res Pract"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722000624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722000624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:39:29Z","timestamp":1758645569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817722000624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":28,"alternative-id":["S0046817722000624"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2022.03.001","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myeloid sarcoma and extramedullary hematopoiesis expand the spectrum of ERG-positive proliferations: an ancillary tool in the diagnosis","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2022.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}